title: Comparable effects of pioglitazone and perindopril on circulating endothelial progenitor cells, inflammatory process and oxidative stress in patients with diabetes mellitus.
authors.forename: Anna-Maria
authors.initials: AM
authors.lastname: Kampoli
authors.forename: Dimitris
authors.initials: D
authors.lastname: Tousoulis
authors.forename: Zoi
authors.initials: Z
authors.lastname: Pallantza
authors.forename: George
authors.initials: G
authors.lastname: Paterakis
authors.forename: Nikolaos
authors.initials: N
authors.lastname: Papageorgiou
authors.forename: Evangelos
authors.initials: E
authors.lastname: Oikonomou
authors.forename: Antigoni
authors.initials: A
authors.lastname: Miliou
authors.forename: Argiro
authors.initials: A
authors.lastname: Vlachopoulou
authors.forename: Christodoulos
authors.initials: C
authors.lastname: Stefanadis
mesh_terms: D000368:Aged; D003920:Diabetes Mellitus / Q000097:blood / Q000188:drug therapy*; D042783:Endothelial Cells / Q000187:drug effects* / Q000378:metabolism; D005260:Female; D006412:Hematopoietic Stem Cells / Q000187:drug effects / Q000378:metabolism / Q000473:pathology*; D006801:Humans; D007249:Inflammation / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D018384:Oxidative Stress / Q000187:drug effects* / Q000502:physiology; D020913:Perindopril / Q000627:therapeutic use*; D000077205:Pioglitazone; D045162:Thiazolidinediones / Q000627:therapeutic use*
chemical_list: D045162:Thiazolidinediones; D000077205:Pioglitazone; D020913:Perindopril